Knavon Retard (Ketoprofen)

Ketoprofen blocks the cyclo‑oxygenase enzymes COX‑1 and COX‑2, which are essential for producing prostaglandins. By reducing prostaglandin synthesis, the drug diminishes the inflammatory response, lowers pain‑signal transmission, and helps control fever.

The exact dosage of Knavon Retard is determined by the prescribing clinician based on the patient’s condition, age, weight, renal and hepatic function, and other individual factors. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Ketoprofen is generally avoided during the third trimester of pregnancy because of potential risks to the fetus. Use during any stage of pregnancy or while breastfeeding should only occur if the prescriber judges that the benefits outweigh the risks and after a careful assessment.

To order Knavon Retard, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Ketoprofen, the active ingredient in Knavon Retard, has a potency comparable to ibuprofen and naproxen but may offer a longer duration of analgesic effect for some patients. Its safety profile is similar to other NSAIDs, with comparable gastrointestinal and renal considerations, so choice often depends on clinician preference and patient tolerance.

Knavon Retard should be stored at ambient temperature, preferably below 25 °C. Keep the tablets in the original blister pack or container, protect them from moisture, heat and direct sunlight to maintain stability and potency.

Knavon Retard is taken orally with a full glass of water. It can be taken with or without food, although taking it with food may reduce gastrointestinal discomfort. The exact timing and frequency are set by the prescribing healthcare professional.

The most serious risks include gastrointestinal ulceration or bleeding, severe renal impairment, life‑threatening skin reactions such as Stevens‑Johnson syndrome, and anaphylaxis. Patients should be monitored for signs of these conditions and seek immediate medical attention if they occur.

Knavon Retard should be avoided in individuals with known hypersensitivity to ketoprofen or other NSAIDs, active gastrointestinal ulcer or bleeding, severe heart failure, uncontrolled hypertension, and in the third trimester of pregnancy. It is also contraindicated in patients with severe renal or hepatic impairment unless specifically directed by a physician.